结直肠肿瘤免疫治疗机制研究/脑肠互动异常性疾病机制研究/肠道微生态与免疫、消化道动力等机制研究

Research on the mechanisms of immunotherapy for colorectal tumors/Research on the mechanisms of gut–brain interaction disorders/Research on the Mechanisms of Gut Microbiota in relation to immunity, and gastrointestinal motility.

任职87978797威尼斯老品牌附属第十人民医院功能肠道外科主任、上海人体肠道菌群功能开发工程技术研究中心主任、上海市重中之重（肠道微生态）临床研究中心主任。中华医学会肠外肠内营养分会微生态协作组组长，中国人体健康科技促进会肠道微生态与肠菌移植专委会常委，中国医师协会外科医师分会临床营养医师专家工作组秘书，中国抗癌协会肿瘤营养专业委员会肿瘤外科营养专家协作组委员，上海市预防医学会微生态专业委员会副主任委员和上海市医师协会肛肠医师委员会委员等学术任职。

The Director of the Department of Functional Intestinal Surgery at Shanghai Tenth People’s Hospital, Tongji University; Director of the Shanghai Engineering Research Center of Human Intestinal Microbiota Function; and Director of the Shanghai Key Clinical Research Center for Intestinal Microecology. The Head of the Microecology Collaboration Group of Society of Parenteral and Enteral Nutrition, Chinese Medical Association; Standing Committee Member of the Gut Microecology and Fecal Microbiota Transplantation Committee of the China Association for the Promotion of Human Health Science and Technology; Secretary of the Clinical Nutrition Physician Expert Working Group of the Chinese Medical Doctor Association; Member of the Tumor Surgical Nutrition Expert Collaboration Group of the Tumor Nutrition Committee of the Chinese Anti-Cancer Association; Vice Chairman of the Microecology Committee of the Shanghai Preventive Medicine Association; and Member of the Colorectal Surgeon Committee of the Shanghai Medical Doctor Association.

以主要完成人获上海市科技进步奖一等奖，上海市医学科技奖一等奖，教育部科技进步奖二等奖，中华医学科技奖三等奖和江苏省科技进步奖二等奖等各一项，获上海市东方英才拔尖人才和海市第十九届银蛇奖提名奖等人才项目，我国肠道菌群移植创建者和标准制定者，牵头发表相关指南规范7部，以第一作者或通讯作者发表SCI论文30余篇，包括Lancet Gastroenterol Hepatol（2022）， Gastroenterology（2022），Gut microbes（2023），Cell Host & Microbe（2024），Science Bulletin（2025）和Nucleic Acids Research（2025）等国际著名期刊，总影响因子＞200分，主持国家和省部级课题10余项，获得国家发明专利8项，多篇研究成果被国际指南所引用。

As a leading contributor, I have received several prestigious awards, including the First Prize of the Shanghai Science and Technology Progress Award, the First Prize of the Shanghai Medical Science and Technology Award, the Second Prize of the Ministry of Education Science and Technology Progress Award, the Third Prize of the Chinese Medical Science and Technology Award, and the Second Prize of the Jiangsu Provincial Science and Technology Progress Award. I have been selected for talent programs such as the Shanghai “Oriental Talent Program” and was nominated for the 19th Silver Snake Award of Shanghai. As one of the founders and standard-setters of fecal microbiota transplantation (FMT) in China, I led the development and publication of seven national guidelines and expert consensuses in this field. As the first or corresponding author, I have published more than 30 SCI-indexed papers in internationally renowned journals, including The Lancet Gastroenterology & Hepatology (2022), Gastroenterology (2022), Gut Microbes (2023), Cell Host & Microbe (2024), Science Bulletin (2025), and Nucleic Acids Research (2025), with a total impact factor exceeding 200. I have presided over more than ten national and provincial research projects, hold eight national invention patents, and several of my research findings have been cited in international clinical guidelines.